Zhejiang Yongtai is an API manufacturer based in China. It holds 8 active US drug master files across a filed portfolio of 7 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 14 March 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| China, China | 3008828051 |
| Molecule | Regulators | Docs |
|---|---|---|
| Metoprolol | US FDA | 2 |
| Celecoxib | US FDA | 1 |
| Duloxetine | US FDA | 1 |
| Esomeprazole | US FDA | 1 |
| Fenofibrate | US FDA | 1 |
| Rosuvastatin | US FDA | 1 |
| Sitagliptin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 8 | 1 |
Choose your molecules and target markets. Zhejiang Yongtai comes back tiered against every other supplier able to file there.
Start for free